Occupational Exposures to per- and Polyfluoroalkyl Substances (PFAS): Evaluating Serum PFAS Concentrations in Municipal Firefighters and the Relationship Between PFAS and COVID-19 Severity in Frontline and Other Essential Workers
Year: 2023
Type: dissertation
Study design: Observational Study
Abstract: Background: Per- and polyfluoroalkyl substances (PFAS) are synthetic, persistent organic compounds that have been associated with various adverse health effects. While studies have shown that firefighters have elevated PFAS concentrations compared to the general population, more research is needed to understand the extent to which firefighting as an occupation contributes to greater PFAS body burden. There is also a significant gap in our understanding whether PFAS exposures alter immune responses in adults, especially among occupational workers who have a higher risk of exposure to PFAS. Firefighters and other essential workers are at an increased risk of contracting infectious diseases due to their close contact with one another and the general population, and PFAS exposure may exacerbate these risks. This information is critical to inform the development of targeted interventions and prevention strategies to mitigate the adverse health outcomes associated with PFAS exposure. Objectives: The objectives of this study are to compare serum PFAS concentrations between incumbent and recruit firefighters, to evaluate changes in PFAS concentrations over time and their association with cumulative fire exposures among recruits, and to investigate the relationship between serum PFAS concentrations and the severity of COVID-19 illness in essential workers. Methods: We conducted a cross-sectional study to compare serum PFAS concentrations in 99 incumbent and 55 recruit firefighters. Linear and logistic regression models were used to examine cross-sectional measures of PFAS from incumbents and recruits. To assess longitudinal trends in PFAS and their association with cumulative fire exposures, serum concentrations of nine PFAS were measured at study enrollment and 20-37 months later in the 55 recruits. Linear mixed effects models and generalized estimating equations were used to assess longitudinal trends. Exposure assessment surveys were used to assess cumulative and most recent fire exposures in the 55 recruits, and these exposures were analyzed for associations with PFAS concentrations using linear and logistic regression models. To investigate the relationship between elevated serum PFAS concentrations and COVID-19 symptom severity in frontline and other essential workers, we conducted complete-case analyses using self-reported outcomes of COVID-19 disease severity (i.e., illness duration, days sick in bed, health status on worst day of illness, febrile, and fever duration). Serum concentrations of perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), and perfluoroundecanoate (PFUnDA) were measured in a cohort of 392 frontline and other essential workers between August 2020 and August 2021. Participant provided weekly biospecimens and questionnaires. Eligible participants for this study included frontline and other essential workers with PFAS serum measurements who tested positive for SARS-CoV-2 during the study period and had not received a COVID-19 vaccination prior to or during their illness. We fit a series of adjusted models using linear or logistic regression, hurdle, and quasi-Poisson modeling methods. Results: Cross-sectional results show that, at enrollment, serum concentrations of two PFAS compounds, linear PFOA (n-PFOA) and perfluorononanoate (PFNA), were significantly lower in incumbents than in recruits. Temporal trends among recruits showed declining serum concentrations for linear PFOS (n-PFOS), monomethyl branched isomers of PFOS, n-PFOA, PFNA, and perfluorodecanoate (PFDA), and detection frequency decreased for 2-(N-methyl-perfluorooctane sulfonamide) acetate (MeFOSAA). However, no significant associations with cumulative fire exposures were observed. Regarding the relationship between PFAS serum concentrations and COVID-19 severity, we found no significant associations between PFHxS, PFOS, or PFUnDA and illness duration, illness severity on worst day, or febrile condition. However, for days sick in bed, we observed a modestly significant increase in the probability of having more than one day sick in bed per ng/mL increase in PFHxS and having at least one day sick in bed per log(ng/mL) increase in PFHxS. Additionally, PFHxS had a significant positive association with fever duration. Conclusions: Our research found that serum PFAS concentrations were not significantly higher in incumbent firefighters than recruits and that cumulative fireground exposure was not significantly associated with serum PFAS concentrations in recruits, indicating that firefighting may not be a major contributor to overall PFAS exposure in these individuals. However, the increased detection frequency for Sb-PFOA in recruit firefighters suggests that there are other sources of PFAS exposure in this population, such as contaminated food or water. In terms of COVID-19 severity, our findings suggest that exposure to PFHxS may be associated with increased illness duration and fever in individuals with COVID-19. This highlights the importance of frontline and other essential workers continuing to follow recommended safety precautions to prevent COVID-19 infection. Furthermore, efforts to reduce PFAS exposure should also be pursued to minimize potential adverse health outcomes. However, additional research is necessary to further investigate this relationship and to understand the underlying mechanisms involved.
Authors: Nematollahi, Amy Johanna, Nematollahi, Amy Johanna
Institution: University of Arizona
Language: English
Subfield: Environmental Chemistry
Field: Environmental Science
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W7041914229
